ARRY at Wells Fargo Healthcare

BOULDER, Colo., Aug. 28, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Wells Fargo Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event:
Wells Fargo Healthcare Conference
Presenter:
Ron Squarer, Chief Executive Officer
Date:
Wednesday, September 6, 2017
Time:
9:05 a.m. Eastern Time
Webcast:
cc.talkpoint.com/well001/090617a_as/?entity=65_KJWP5P3
Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).

CONTACT:
Tricia Haugeto

Array BioPharma Inc.

303-386-1193

thaugeto@arraybiopharma.com